SAM
NBRV

Sectoral Asset Management’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Sectoral Asset Management’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-153
Closed -$93K – 91
2019
Q2 		$93K Hold
153
– – 0.01% 84
2019
Q1 		$93K Hold
153
– – 0.01% 100
2018
Q4 		$56K Hold
153
– – 0.01% 99
2018
Q3 		$103K Buy
+153
New +$108K 0.01% 160

Other funds holding NBRV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sectoral Asset Management's NBRV Position: Q3 2019 in Review

Sectoral Asset Management sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q3 2019, closing a stake of 153 shares — an estimated $93K sold.

Sectoral Asset Management first reported a position in NBRV in Q3 2018 and held it in 4 quarters. The position peaked at $103K in Q3 2018. 44 funds tracked by Wall St. Rank hold NBRV as of Q3 2019.

  • Sectoral Asset Management reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q3 2019 after selling out during the quarter.
  • Sectoral Asset Management sold 153 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q3 2019, an estimated $93K.
  • Sectoral Asset Management first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2018 and held it in 4 quarters.
  • Sectoral Asset Management's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $103K in Q3 2018.
  • 44 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q3 2019.

Based on Sectoral Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.